Search


Galápagos CEO Paul Stoffels on the company's $3.8B cash balance and decentralized CAR-T program
Paul Stoffels describes how his company's decentralized CAR-T process is designed to have a shorter 'brain-to-vein' time.
Jan 9, 2024
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.